Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group
James B. Nachman(University of Chicago), Nita L. Seibel(National Cancer Institute), Peter G. Steinherz(Memorial Sloan Kettering Cancer Center), Caroline A. Hastings(UCSF Benioff Children's Hospital), Leonard A. Mattano, Meenakshi Devidas(National Institutes of Health), David R. Freyer(University of Southern California), Mei La(Arcadia), Nyla A. Heerema(The Ohio State University), Stephen P. Hunger(Children's Hospital of Philadelphia), Harland N. Sather(Children's Oncology Group), Paul S. Gaynon(University of Southern California)
Cited by 133
Related Papers
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|1.2k